EASD 2024

Sales & Marketing

This September, Madrid played host to the 60th Annual Meeting of the European Association for the Study of Diabetes (EASD).

News

Hengrui's oral TPO agonist, hetrombopag, is the first in the class to be approved for thrombocytopenia caused by chemotherapy for solid tumours.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.